Mingchao Wang

Mingchao Wang

Auto-generated profile, based on publicly available information

Mingchao Wang

Tsinghua University-Peking University Joint Center for Life Sciences, Tsinghua University, Beijing, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2022 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
HXHaiyun Xie
Haiyun Xie
MWMingchao Wang
Mingchao Wang
HYHaifeng Yu
Haifeng Yu
HWHuan Wang
Huan Wang
LDLifeng Ding
Lifeng Ding
GLGonghui Li
Gonghui Li
7-methylguanosine (m7G) modification is recently found to conservatively exist in RNA internal position besides mRNA caps and mediates the various RNA metabolisms. As the core confirmed transmethylase of m7G modification, METTL1 has been reported in certain human cancers. However, the role of internal m7G at miRNAs and its core writer METTL1 in bladder cancer (BCa) remains to be elucidated. Here, we demonstrated that METTL1 was indispensable for BCa proliferation and metastasis in vitro and in vivo. By combining miRNA sequencing, m7G methylated RNA immunoprecipitation (MeRIP) and RIP, we identified METTL1 promoted the processing of miR-760 in an m7G-dependent manner. Transcription sequencing suggested that METTL1 indirectly degrades tumor suppressor ATF3 mRNA mediated by miR-760. Together, we concluded a regulatory axis composed of METTL1/m7G/miR-760/ATF3 in regulating BCa progression and provided potential therapeutic targets for BCa.

17 November 2025 in Cancer Research
Verified
Journal Article
Closed access
MWMingchao Wang
Mingchao Wang
ZSZhihong Song
Zhihong Song
HYHao Yuan
Hao Yuan
CLChang Liu
Chang Liu
WWWei Wang
Wei Wang
XLXun Lan
Xun Lan
Cancer cells are able to evade immunosurveillance by engendering an immunosuppressive “cold” tumor microenvironment (cTME). A better understanding of the mechanisms underlying the establishment of a cTME in the initial phases of tumor formation could help uncover improved immunotherapeutic strategies. To characterize the temporal dynamics of the formation of a cTME, we generated single-cell RNA sequencing data during the initiation phases of EGFR-driven lung adenocarcinoma. Macrophages in the tumor microenvironment (TME) underwent a state transition from antitumor macrophages to protumor macrophages, which orchestrated the formation of a cTME. Tumor cell–derived BMP2/4 induced the polarization of protumor macrophages, and inhibiting the BMP2/4–ACVR1 axis with an ACVR1 inhibitor converted the cTME into a “hot” TME, resulting in a potent suppression of tumor growth. Furthermore, patients with EGFR-mutant lung adenocarcinoma exhibited similar cTME characteristics to those observed in mice, and high expression of ACVR1 correlated with worse patient prognosis. Overall, in addition to elucidating the role of protumor macrophages in cTME formation, this study pinpoints targeting ACVR1 as a therapeutic strategy for treating EGFR-mutant lung cancers. Significance: In the early stages of lung cancer development, cancer cells reprogram tumor-associated macrophages via BMP2/4-ACVR1 signaling to stimulate the formation of an immunosuppressive tumor microenvironment, establishing ACVR1 as a potential immunotherapeutic target.

19 February 2026
Verified
Other
Open access
PDF file
MWMingchao Wang
Mingchao Wang
ZSZhihong Song
Zhihong Song
HYHao Yuan
Hao Yuan
CLChang Liu
Chang Liu
WWWei Wang
Wei Wang
XLXun Lan
Xun Lan
Extended Data Fig.1. EGFR driven lung adenocarcinoma formation, Related to Figure 1 (A) Schematics of the experimental design for lung cancer induction with doxycycline. Lung tissues were collected for scRNA-seq from mice fed with doxycycline for 0, 1, 2, 4, and 8 weeks. (B) H&E staining images of lung sections from mice fed with doxycycline at the indicated time points, highlighting a rapid increase in overall cell density in the mouse lung. Scale bar :50um. (C) Longitudinal MRI imaging of mouse lungs during tumor induction at 0, 1, 2, 4, 6, and 8 weeks. The serial images illustrate the progressive development of lung adenocarcinoma features over time. (D) Immunofluorescence staining for EGFR (green), Ki67 (red) along with DNA visualized by DAPI staining. Scale bar : 50um.

19 February 2026
Verified
Other
Open access
PDF file
MWMingchao Wang
Mingchao Wang
ZSZhihong Song
Zhihong Song
HYHao Yuan
Hao Yuan
CLChang Liu
Chang Liu
WWWei Wang
Wei Wang
XLXun Lan
Xun Lan
Extended Data Fig.8. Inhibition of the BMP2/4-ACVR1 axis transforms the ‘cold’ tumor to a ‘hot’ state, related to Figure 6 (A) H&E strain images of lung sections derived from mice under indicated treatments showing that DMH1 treatment significantly reduced the tumor burden in the mouse lung. Scale bar :50um. (B) Box plot showing the proportions of Treg, T cells, neutrophils and monocytes (from left to right) at 0w, 4 weeks induction and 4 weeks induction with DMH1. (C) Bar plot quantifying the proportions of various types of non-immune cells at each time point, highlighting a rapid expansion of cancer cells. (D) Bar plot showing changes in CD8⁺ T cells. Left: Percentage of CD8⁺ T cells among total CD45⁺ immune cells in lung tissue at baseline (0W), after 4 weeks of tumor induction without LDN treatment (4W), and after 4 weeks of tumor induction with LDN treatment initiated at week 2(4W+LDN). Right: Absolute number of CD8⁺ T cells per mg of lung tissue. LDN was administered via intraperitoneal injection starting from week 2 of tumor induction. (E) Barplot of Median fluorescence intensity (MFI) of IFNγ expression in CD8⁺ T cells. (F) Weight of mice treated with the two different inhibitors (n=5). Showing no significant weight loss over the course of the treatment. (G) Flow cytometry plots of early apoptosis cells of PC9 cell line (PI-AnnexinV+) and apoptosis cells (PI+AnnexinV+) treated by gefitinib, LDN, and DMH1 for 24 hours. (H) Frequencies (top) of early apoptosis cells of PC9 cell line (PI-AnnexinV+) and apoptosis cells (PI+AnnexinV+) treated by gefitinib, LDN, and DMH1 for 24 hours. (I) The survival rate, as measured by CCK 8, of PC9 cells in indicated groups. (J) Tumor volume in mice bearing PC9 cells under indicated treatments. (K) H&E strain images of lung sections derived from mice under indicated treatments showing that the treatment could still significantly reduced the tumor burden in the mouse lung even in advanced tumor. Scale bar :50um.

19 February 2026
Verified
Other
Open access
PDF file
MWMingchao Wang
Mingchao Wang
ZSZhihong Song
Zhihong Song
HYHao Yuan
Hao Yuan
CLChang Liu
Chang Liu
WWWei Wang
Wei Wang
XLXun Lan
Xun Lan
Extended Data Fig.4. Macrophage-derived chemokine interactions shift toward Treg recruitment during tumorigenesis, related to Figure 3. (A) Enrichment analysis between Mac_a1 and Mac_a2. (B) Heatmap showing each KEGG pathway contained which genes. Those pathways and genes were related to Figure 3A. (C) Expression levels of selected chemokines and cytokines in the different subtypes of monocytes and macrophages in t-SNE projection. Each color indicates one cell subtype. (D) The expression levels of Ccl17 and Ccl22 in macrophages were assessed via bulk RNA-seq analysis at each time point (n=3 for all time points). (E) Flow cytometry analysis of Treg cells from mouse lung tumors induced with doxycycline (2mg/ml) for 0, 1, 2, and 4 weeks. Flow cytometry plots (left) and frequencies (right) of Treg cells (CD45+CD3+CD4+Foxp3+) at the indicated time points. Each dot represents an individual mouse. Consistent with the single-cell analysis, recruitment of Treg cells was significantly increased after 4 weeks of doxycycline induction. (F) Barplot of flow cytometric analysis of Treg cells (CD45⁺CD3⁺CD4⁺Foxp3⁺) in mouse lung tumors at different doxycycline induction time points: no induction (0 week), 4 weeks, and 8 weeks. Each dot represents an individual mouse. (G) Box plot of Th1/Th2 scores of Mac_d cells at each time point. (H) Heatmap of average expression of Th1 and Th2 like signature genes in Mac_d cells at each time point. Each column represents one single cell and each row represents one gene. The expression levels were standardized by taking the z-score within each row. The top bar indicates the time points. The left bar denotes the Th1/Th2 marker genes. (I) Box plot of T cell cytotoxity (Left), activation (Middle) and exhaustation (Right) scores of CD8+ T cells at each time point. (J) Parallel plot of Transcription factor and target relationships. Targets were Th1 like markers whose expression changed significantly between Mac_b and Mac_c.

19 February 2026
Verified
Other
Open access
PDF file
MWMingchao Wang
Mingchao Wang
ZSZhihong Song
Zhihong Song
HYHao Yuan
Hao Yuan
CLChang Liu
Chang Liu
WWWei Wang
Wei Wang
XLXun Lan
Xun Lan
Extended Data Fig.7 Inhibition of the BMP2/4-ACVR1 axis reverses macrophage polarization, related to Figure 5 (A) The expression of representative marker genes superimposed on the t-SNE plots. Each color indicates a subtype of alveolar macrophages. (B) Heatmap showing the expression pattern of the top 10 marker genes for each subtype of alveolar macrophages, determined using Seurat. (C) Depiction of a network for ligand-receptor interactions (LRIs) among different cell types in mouse lungs treated with DOX+LDN. Each node represents a cell type. The size of each node shows the number of LRIs occurring for each given cell type. The width of the edges represents the number of significant LRIs between the two types of cells in mouse lungs treated with DOX+LDN, subtracting the number of LRIs at week 0. (D) The log2 transformed number of trans-ligands (ligand and receptor expressed in different types of cells) of each cell type in the cell–cell communication network in panel A, indicating that macrophages function as central mediators in mouse lungs treated with DOX+LDN. (E) Heatmap showing each KEGG pathway contained which genes. Those pathways and genes were related to Figure 5D. (F) Hierarchical clustering of the expression levels of macrophage-specific chemokines in alveolar macrophages of mouse lungs under indicated treatments. The treatment groups are indicated at the top; the cell types are indicated at the bottom. (G) Heatmap of the average expression of ATM and PTM associated genes in alveolar macrophages in the indicated treatment group. Each column represents a single cell, and each row represents one gene. The expression levels were standardized by taking the z-score within each row. (H) Box plot of ATM/PTM scores (calculated based on marker genes from Li et. al., see STAR Methods in the method section for details) of alveolar macrophages in mouse lungs with indicated treatment.